Cargando…

Use of Ceftaroline in Hospitalized Patients with and without COVID-19: A Descriptive Cross-Sectional Study

A single-center cross-sectional study was conducted to describe the use of ceftaroline in a large teaching hospital in Northern Italy, during a period also including the first months of the coronavirus disease 2019 (COVID-19) pandemic. The primary objective was to describe the use of ceftaroline in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giacobbe, Daniele Roberto, Russo, Chiara, Martini, Veronica, Dettori, Silvia, Briano, Federica, Mirabella, Michele, Portunato, Federica, Dentone, Chiara, Mora, Sara, Giacomini, Mauro, Berruti, Marco, Bassetti, Matteo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300614/ https://www.ncbi.nlm.nih.gov/pubmed/34201722 http://dx.doi.org/10.3390/antibiotics10070763

Ejemplares similares

Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy
por: Vena, Antonio, et al.
Publicado: (2020)

Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care
por: Taramasso, Lucia, et al.
Publicado: (2021)

T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2022)

Higher Mortality and Intensive Care Unit Admissions in COVID-19 Patients with Liver Enzyme Elevations
por: Taramasso, Lucia, et al.
Publicado: (2020)

Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19
por: Baldi, Federico, et al.
Publicado: (2023)

Prevalence of Viral Hepatitis in Unselected, Consecutively Enrolled Patients Hospitalised for SARS-CoV-2
por: Dettori, Silvia, et al.
Publicado: (2022)

Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
por: Mikulska, Malgorzata, et al.
Publicado: (2020)

Early Detection of Sepsis With Machine Learning Techniques: A Brief Clinical Perspective
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2021)

Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2021)

Machine Learning and Multidrug-Resistant Gram-Negative Bacteria: An Interesting Combination for Current and Future Research
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2020)

Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors
por: Briano, Federica, et al.
Publicado: (2022)

Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19”
por: Nicolini, Laura Ambra, et al.
Publicado: (2020)

Ten Years of Medical Informatics and Standards Support for Clinical Research in an Infectious Diseases Network
por: Mora, Sara, et al.
Publicado: (2023)

Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy
por: Russo, Elisa, et al.
Publicado: (2020)

Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression
por: Vena, Antonio, et al.
Publicado: (2022)

Respiratory Fungal Diseases in Adult Patients With Cystic Fibrosis
por: Delfino, Emanuele, et al.
Publicado: (2019)

Ceftaroline
por: Soriano, Alex
Publicado: (2021)

New antibiotics for the treatment of nonfermenting Gram-negative bacteria
por: Bassetti, Matteo, et al.
Publicado: (2021)

Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2022)

Intermediate monocytes expansion and homing markers expression in COVID-19 patients associate with kidney dysfunction
por: Dentone, Chiara, et al.
Publicado: (2022)

Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination
por: Dentone, Chiara, et al.
Publicado: (2022)

Mind the gap: IgG4-related disease mimicking infectious cerebral mass lesions
por: De Maria, Andrea, et al.
Publicado: (2022)

Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia
por: Taramasso, Lucia, et al.
Publicado: (2019)

Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2023)

Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection
por: Sarteschi, Giovanni, et al.
Publicado: (2020)

New antibiotics for Gram-negative pneumonia
por: Bassetti, Matteo, et al.
Publicado: (2022)

Spread of Carbapenem-Resistant Gram-Negatives and Candida auris during the COVID-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship?
por: Magnasco, Laura, et al.
Publicado: (2021)

Emerging Treatment Options for Acute Bacterial Skin and Skin Structure Infections and Bloodstream Infections Caused by Staphylococcus aureus: A Comprehensive Review of the Evidence
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2022)

Early Administration of Bamlanivimab in Combination with Etesevimab Increases the Benefits of COVID-19 Treatment: Real-World Experience from the Liguria Region
por: Vena, Antonio, et al.
Publicado: (2021)

Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance
por: Bassetti, Matteo, et al.
Publicado: (2020)

A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic
por: Bassetti, Matteo, et al.
Publicado: (2020)

Ceftaroline-related acute eosinophilic pneumonia
por: Min, Zaw, et al.
Publicado: (2021)

Ceftaroline in severe community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

A Case of Ceftaroline-Associated Thrombocytopenia
por: Jagadish, Ashwin, et al.
Publicado: (2023)

Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis
por: Sotgiu, Giovanni, et al.
Publicado: (2018)

External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2023)

Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central Italy
por: Morroni, Gianluca, et al.
Publicado: (2021)

Ceftaroline in complicated skin and skin-structure infections
por: Hernandez, Paul O, et al.
Publicado: (2012)

Ceftaroline Fosamil: A Brief Clinical Review
por: Shirley, Debbie-Ann T., et al.
Publicado: (2013)

204. Clinical Outcomes with Ceftaroline Monotherapy versus Daptomycin-Ceftaroline Combination Therapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Andonie, Gabriela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pkclndidr9dcabi13b65n3lnne